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Abstract
Retinoic acid (RA) is known to regulate definitive myelopoiesis but its role in vertebrate primitive myelopoiesis remains
unclear. Here we report that zebrafish primitive myelopoiesis is restricted by RA in a dose dependent manner mainly before
11 hpf (hours post fertilization) when anterior hemangioblasts are initiated to form. RA treatment significantly reduces
expressions of anterior hemangioblast markers scl, lmo2, gata2 and etsrp in the rostral end of ALPM (anterior lateral plate
mesoderm) of the embryos. The result indicates that RA restricts primitive myelopoiesis by suppressing formation of
anterior hemangioblasts. Analyses of ALPM formation suggest that the defective primitive myelopoiesis resulting from RA
treatment before late gastrulation may be secondary to global loss of cells for ALPM fate whereas the developmental defect
resulting from RA treatment during 10–11 hpf should be due to ALPM patterning shift. Overexpressions of scl and lmo2
partially rescue the block of primitive myelopoiesis in the embryos treated with 250 nM RA during 10–11 hpf, suggesting RA
acts upstream of scl to control primitive myelopoiesis. However, the RA treatment blocks the increased primitive
myelopoiesis caused by overexpressing gata4/6 whereas the abolished primitive myelopoiesis in gata4/5/6 depleted
embryos is well rescued by 4-diethylamino-benzaldehyde, a retinal dehydrogenase inhibitor, or partially rescued by
knocking down aldh1a2, the major retinal dehydrogenase gene that is responsible for RA synthesis during early
development. Consistently, overexpressing gata4/6 inhibits aldh1a2 expression whereas depleting gata4/5/6 increases
aldh1a2 expression. The results reveal that RA signaling acts downstream of gata4/5/6 to control primitive myelopoiesis. But,
4-diethylamino-benzaldehyde fails to rescue the defective primitive myelopoiesis in either cloche embryos or lycat
morphants. Taken together, our results demonstrate that RA signaling restricts zebrafish primitive myelopoiesis through
acting downstream of gata4/5/6, upstream of, or parallel to, cloche, and upstream of scl.
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Introduction
Vertebrate hematopoiesis arises successively in primitive and
definitive waves at anatomically distinct sites during development
[1]. Zebrafish primitive hematopoiesis occurs in the rostral end of
anterior lateral plate mesoderm (ALPM) that is also known as
rostral blood island (RBI), and the intermediate cell mass (ICM)
that is an analog to extraembryonic yolk sac blood islands of
mammals and birds [2]. RBI produces myeloid cells, head
endothelium and endocardium whereas ICM, derived from
posterior lateral plate mesoderm (PLPM), gives rise to erythro-
cytes, endothelial linage and a few myeloid cells [2,3]. Zebrafish
definitive hematopoiesis begins within the ventral wall of dorsal
aorta in an aorta-gonad-mesonephros region at about 31 hpf (hour
post fertilization). The precursors later colonize into kidney
marrow (the equivalent of avian and mammalian bone marrow),
thymus and pancreas, in which hematopoietic stem cells
differentiate into erythroid, myeloid, and lymphoid lineages for
lifetime [2,3,4].
Zebrafish primitive myelopoiesis is initiated in RBI to form
anterior hemangioblasts marked by expressing transcription
factors scl, lmo2, gata2 and etsrp between 3- to 5-somite stages
[2,3,5]. With development, a subset of the scl
+ precursors acquire
myeloid cell fates by expressing myeloid-specific transcription
factor pu.1 (also known as spi1) [6,7]. During 11- to 15-somite
stages, the pu.1
+ precursors migrate toward head midline. They
partially converge between eye and heart primordium and then
abruptly migrate laterally, scattering into single cells across yolk
sac [7,8,9]. After 18-somite stage, the precursors decline their pu.1
expression but express mature myeloid-markers such as lcp1
(lymphocyte cytosolic plastin 1, also known as l-plastin) identifying
all myeloid cells including macrophages and neutrophils, csf1r
(colony stimulating factor 1 receptor, also known as fms) marking
macrophages and mpx (myeloperoxidase, also known as mpo)
labeling neutrophils, respectively [6,7,8,10]. It is believed that
some macrophages later migrate posteriorly toward ICM whereas
the myeloid precursors originated in ICM give rise to at least some
granulocytes there [11]. The myeloid cells eventually develop into
functional cells as early as 26 hpf [8].
Retinoic acid (RA), a derivative of vitamin A, not only plays
crucial roles in vertebrate early development but also influences
growth and differentiation of different adult cell types [12]. Since
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leukemia (APL) through promoting terminal granulocytic differen-
tiation of malignant promyelocytes in the late 1980s [13], a number
of studies have been performed to assess roles of RA signaling in
regulating normal myelopoiesis [14,15]. In vitro cell culture studies
on the hematopoietic precursor cells derived from normal bone
marrow or fetal liver suggest that RA generally enhances growth
and differentiation of granulocyte progenitors [15] but may have
different effects on hematopoietic cells depending on their
maturational states [15,16]. Analyses of the female SENCAR mice
fed a vitamin A-deficient (VAD) diet reveal that shortage of RA
signaling causes a dramatic expansion of myeloid cells in bone
marrow, spleen and peripheral blood whereas addition of RA to the
VAD diet completely reverses the abnormality [17]. The in vivo
results suggestthat the myeloidcellexpansion isa directresult ofRA
deficiency. Consistent with the VAD mice, both cellular retinol-
binding protein type I (CRBPI) knockout mice fed a VAD diet and
the mice treated with RA receptor (RAR) antagonist BMS493
display a similar expansion of myeloid cells associated with an
increase in immature granulocytes [18].
Although a lot of researches have been performed on analyzing
roles of RA signaling in definitive myelopoiesis and differentiation
of myeloid cells, its roles in primitive myelopoiesis remain
unknown. In this study, we report that excessive RA suppresses
zebrafish primitive myelopoiesis by restricting formation of
anterior hemangioblasts in a dose dependent way. The defective
myelopoiesis resulting from RA treatment before the end of
gastrulation may be secondary to global loss of cells for ALPM fate
whereas the defect resulting from RA treatment during 10–11 hpf
should be ascribed to ALPM patterning shift. Performing analyses
of epistatic relationships between RA signaling and the genes
controlling zebrafish primitive myelopoiesis, we demonstrate that
RA signaling acts downstream of gata4/5/6, upstream of, or
parallel to, cloche, and upstream of scl to restrict zebrafish primitive
myelopoiesis.
Results
RA inhibits zebrafish primitive myelopoiesis in a dose
dependent way
To examine roles of RA signaling in primitive myelopoiesis, we
treated zebrafish embryos with RA at concentrations of 6.25, 12.5,
25 and 50 nM from 1–2-cell stage through 26 hpf, respectively.
We then analyzed their expressions of myeloid cell markers lcp1
and mpx at 26 hpf [6,8,10]. In control embryos, cells expressing
lcp1 and mpx were found to disperse throughout embryos
(Figure 1A and 1G). The number of cells expressing lcp1 and
mpx was slightly reduced in the embryos treated with 6.25 nM RA
(Figure 1B and 1H), significantly reduced in the embryos treated
with 12.5 nM RA (Figure 1C and 1I) and 25 nM RA (Figure 1D
and 1J), and almost completely abolished in the embryos treated
with 50 nM RA (Figure 1E and 1K). The results demonstrate that
exogenous RA inhibits zebrafish primitive myelopoiesis dose-
dependently.
To examine whether elevation of endogenous RA levels by
depleting Cyp26s, the enzymes responsible for metabolizing RA in
vivo [12], limits zebrafish primitive myelopoiesis, we examined
expressions of lcp1 and mpx in cyp26s morphants at 26 hpf. When
embryos were microinjected with control morpholino (MO), they
displayed normal expressions of lcp1 and mpx (data not shown).
However, the embryos microinjected with cyp26s-specific MOs
exhibited significantly reduced number of cells expressing lcp1 and
mpx (Figure 1F and 1L). Quantitative analysis by real-time PCR
confirmed that expression levels of both lcp1 and mpx in cyp26s
morphants were significantly lower than (P,0.05) those in control
embryos (Figure S1). The results reveal that cyp26s involve the
maintenance of normal primitive myelopoiesis in zebrafish.
RA plays its repressive role in zebrafish primitive
myelopoiesis mainly before 11 hpf
To determine when RA plays its repressive roles in zebrafish
primitive myelopoiesis, we examined expressions of myeloid
markers lcp1 and mpx in the embryos treated with 50 nM RA from
3 to 5, 5 to 7, 7 to 9, 9 to 11, 11 to 13, and 13 to 26 hpf, respectively.
The results showed that almost no expression of lcp1 and mpx were
found in the 26 hpf embryos treated with RA for 2 h during 3–5, 5–
7 and 7–9 hpf (Figure 2B–D and 2I–K), and onlya fewmyeloidcells
expressing lcp1 and mpx (Figure 2E and 2L) were found in the
embryos treated with RA during 9–11 hpf. However, less affected
expressions of lcp1 and mpx were found in the embryos treated with
RA during 11–13 hpf (Figure 2F and 2M) and nearly normal
primitive myelopoiesis were found in the embryos treated with RA
during 13–26 hpf (Figure 2G and 2N). The results suggest that RA
signaling plays its repressive role in inhibiting zebrafish primitive
myelopoiesis mainly at the developmental stages before 11 hpf.
Because RA restricts the primitive myelopoiesis in a dose
dependent way (Figure 1), it is interesting to know whether the
less affected and nearly normal primitive myelopoiesis in the
zebrafish embryos treated with RA during 11–13 and 13–26 hpf
respectively (Figure 2G and 2N) is due to the low amount of RA
(50 nM). To test it, we analyzed the embryos treated with 5 times
higher concentration (250 nM) of RA from 10 to 11, 11 to 13, and
13 to 22 hpf respectively. Counting the number of cells expressing
myeloid markers lcp1 in embryos at 22 hpf, we found the control
embryos possessed 80.2617.7 (n=30) lcp1
+ cells (Figure 2O and
2S). The embryos treated with 250 nM RA for 1 h from 10 to 11
hpf only had 2.565.6 (n=27) lcp1
+ cells (Figure 2P and 2S). The
embryos treated with 250 nM RA for 2 h from 11 to 13 hpf held
17.7615.2 (n=30) lcp1
+ cells (Figure 2Q and 2S). The embryos
treated with 250 nM RA from 13 to 22 hpf carried 36.7614.9
(n=32) lcp1
+ cells (Figure 2R and 2S). Though they exhibited
significantly reduced number of lcp1
+ cells compared with control
embryos,theembryostreatedwith250 nMRAfrom11to13hpfor
13 to 22 hpf had much more lcp1
+ cells than the embryos treated
with 250 nM RA for only 1 h from 10 to 11 hpf (Figure 2S). Similar
results were observed when embryos were treated with 1000 nM
RA (data not shown). Taken together, the results demonstrate that
RA plays its repressive roles in zebrafish primitive myelopoiesis
mainly at the developmental stage before 11 hpf and treating
embryos with high concentration of RA (250 nM) during 10–11 hpf
almost abolishes the primitive myelopoiesis.
RA inhibits zebrafish primitive myelopoiesis by
repressing formation of anterior hemangioblasts
Zebrafish primitive myelopoiesis is initiated and specified in
RBI during 11–14 hpf [3,5]. To explore how RA acts to restrict
primitive myelopoiesis, we first detected myeloid precursor maker
pu.1 expression in 14 hpf embryos treated with 50 nM RA from 1–
2-cell stage to 14 hpf or 250 nM RA from 10 to 11 hpf,
respectively. The results showed that expression of pu.1 at 14 hpf
was almost completely abolished in RBI of all the embryos treated
with RA in two different ways (Figure 3B and 3C). Next, we found
expressions of anterior hemangioblast markers scl, lmo2, etsrp and
gata2 were all significantly inhibited in RBI of the RA-treated
embryos at 14 hpf (Figure 3D–O). The results suggest excessive
RA represses formation of anterior hemangioblasts, resulting in
developmental loss of myeloid cells.
RA Restricts Zebrafish Primitive Myelopoiesis
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excessive RA treatment from 1–2-cell to 14 hpf might be
secondary to global loss of ALPM fate whereas the
developmental defect by excessive RA treatment during
10–11 hpf should be due to ALPM patterning shift
Because RA is a posteriorizing factor for patterning anterior–
posterior axis of embryos and excessive RA causes anterior
truncation of embryos [12,19], the defect of anterior hemangio-
blast formation from excessive RA treatment from 1–2-cell to 14
hpf could be due to global loss of ALPM tissue fates. To test this
hypothesis, we first examined hoxb5b expression in the embryos
treated with 50 nM RA from 1–2-cell to 11 hpf. Hoxb5b is a
transcription factor that acts downstream of RA signaling in the
forelimb field to restrict heart field potential in zebrafish embryos
[20]. Normally, it is not expressed in LPM yet but in spinal cord at
11 hpf (Figure 4A) [20]. When embryos were treated with 50 nM
RA from 1–2-cell stage to 11 hpf, we found hoxb5b was strongly
induced to anteriorly expand its expression in spinal cord and
ectopically express in LPM, especially in the presumptive ALPM
of the RA-treated embryos (Figure 4B). Consistently, 25% (7/28)
and 43% (15/35) of the embryos overexpressed with hoxb5b
Figure 1. Excessive RA inhibits primitive myelopoiesis in zebrafish embryos in a dose dependent manner. All embryos are positioned
anterior left and lateral front. Embryos were treated with vehicle DMSO (A, G), 6.25 nM (B, H), 12.5 nM (C, I), 25 nM (D, J) and 50 nM RA (E, K)
respectively from 1–2-cell stage until 26 hpf or microinjected with cyp26a1-MO, cyp26b1-MO and cyp26c1-MO together at 1–2-cell stage (F, L). They
were then examined for expressions of myeloid markers lcp1 (A–F) and mpx (G–L) at 26 hpf by whole mount in situ hybridization. The number shown
in the lower left-hand corner of each panel is the number of embryos exhibiting the typical phenotype shown in the panel to the number of embryos
totally observed.
doi:10.1371/journal.pone.0030865.g001
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PLoS ONE | www.plosone.org 3 February 2012 | Volume 7 | Issue 2 | e30865Figure 2. RA restricts the primitive myelopoiesis mainly before 11 hpf. All embryos are positioned anterior left and lateral front. Embryos
were treated with vehicle DMSO (A, H, O) or with 50 nM RA (B–G, I–N) from 3 to 5 (B, I), 5 to 7 (C, J), 7 to 9 (D, K), 9 to 11 (E, L), 11 to 13 (F, M) and 13 to
26 hpf (G, N), or with 250 nM RA form 10 to 11 (P), 11 to 13 (Q), 13 to 22 hpf (R), respectively. They were then examined for expressions of myeloid
markers lcp1 (A–G, O–R) and mpx (H–N) at 26 hpf (A–N) or 22 hpf (O–R) by whole mount in situ hybridization. The number shown in the lower left-
hand corner of each panel is the number of embryos exhibiting the typical phenotype shown in the panel to the number of embryos totally
observed. The typical embryos expressing lcp1
+ cells at 22 hpf were shown in O–R. The scatter plot (S) shows the number of lcp1
+ cells counted from
each of the embryos at 22 hpf with different treatment (control; 10–11 hpf RA treatment; 11–13 hpf RA treatment and 13–22 hpf RA treatment).
doi:10.1371/journal.pone.0030865.g002
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hpf, respectively (Figure 4D–G); however, knocking down hoxb5b
did not rescue the suppressed primitive myelopoiesis in the RA-
treated embryos (data not shown). Next, we examined gata4
expression in the RA-treated embryos. Gata4 is a transcription
factor that is normally expressed in ALPM of zebrafish embryos
during anterior hemangioblast specification [21]. Treated with
50 nM RA from 1–2-cell stage to 14 hpf, the embryos exhibited
almost abolished expression of gata4 at 14 hpf (Figure 4I). The
results are consistent with the idea that the inhibited formation of
anterior hemangioblast resulting from excessive RA treatment
from 1–2-cell stage to 14 hpf might be ascribed to global loss of
cells for ALPM fate.
To explore direct roles of RA signaling in zebrafish primitive
myelopoiesis, we have to exclude the global effect of excessive RA
on embryonic development. We therefore analyzed the embryos
treated with 250 nM RA for 1 h from 10 hpf to 11 hpf. As shown
in Figure 4C, hoxb5b did not expand its expression to ALPM
though it was indeed induced to expand its expression in spinal
cord and ectopically express in PLPM of the RA-treated embryos.
Consistently, the RA-treated embryos displayed a slightly reduced
gata4 expression in the region between the anterior end of its
expression domain and the anterior end of ntl expression domain
(marker for axial mesoderm) (Figure 4K) compared to control
embryos (Figure 4J) whereas they had a significantly reduced
expression in the region between the posterior end of its expression
domain and the anterior end of ntl expression domain (Figure 4K)
compared to control embryos (Figure 4J). Because the rostral part
of ALPM is responsible for the formation of anterior hemangio-
blasts and its caudal part is responsible for the formation of cardiac
precursors [21], the results strongly suggest that treatment with
RA during 10–11 hpf does not abolish the anterior mesoderm of
ALPM.
Previously, it was identified that embryos with inhibited anterior
hemangioblast specification exhibited ectopic cardiac progenitors
in the rostral portion of ALPM whereas overexpression of
hemangioblast master regulators suppressed the cardiac develop-
ment [22]. Because the 250 nM RA treatment during 10–11 hpf
inhibited formation of anterior hemangioblasts (Figure 3C, 3F, 3I,
3L, 3O), we therefore asked whether the RA treatment skewed the
developmental potential of the rostral tissues into caudal fates. To
answer the question, we examined expression of hand2, the heart
field marker [22,23], in the RA-treated embryos. In normal
embryos, hand2 was confined to the caudal region of ALPM and
whole PLPM (Figure 4L). Treated with 250 nM RA during 10–11
hpf, the embryos exhibited greatly reduced expression of hand2 in
caudal portion of ALPM but ectopical expression of hand2 in the
whole rostral portion of ALPM (Figure 4M). Overexpressed with
scl and lmo2 (master regulators of hemangioblasts), the control
embryos displayed significantly reduced expression of hand2 in the
caudal portion of ALPM (Figure 4N) whereas the RA-treated
embryos showed greatly reduced (15/34) or even completely lost
Figure 3. RA restricts the formation of anterior hemangioblasts in zebrafish embryos. All flat-mounted embryos are positioned anterior
left and dorsal front. Embryos were treated with vehicle DMSO (A, D, G, J, M), 50 nM RA from 1–2-cell stage to 14 hpf (B, E, H, K, N) or 250 nM RA from
10 to 11 hpf (C, F, I, L, O), respectively. They were then examined for expressions of pu.1 (A–C), scl (D–F), lmo2 (G–I), etsrp (J–L), and gata2 (M–O) in the
rostral end of ALPM at 14 hpf by whole mount in situ hybridization. Expression of myoD in somites is used for staging. Bracket indicates the location
of RBI. The number shown in the lower left-hand corner of each panel is the number of embryos exhibiting the typical phenotype shown in the panel
to the number of embryos totally observed.
doi:10.1371/journal.pone.0030865.g003
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in the caudal portion of ALPM (Figure 4O). The results suggest
that RA treatment during 10–11 hpf shifts ALPM patterning by
skewing the developmental potential of rostral tissues into the
caudal fate.
RA signaling acts upstream of scl/lmo2 to control
zebrafish primitive myelopoiesis
scl and lmo2 are known the two key master regulators for
regulating anterior hemangioblasts [22]. Because the 250 nM RA
treatment during 10–11 hpf inhibited expressions of anterior
hemangioblasts master regulators scl and lmo2 (Figure 3C, 3F, 3I,
3L, and 3O), we hypothesized that RA signaling acts upstream of
scl/lmo2 to control zebrafish primitive myelopoiesis. To confirm
this hypothesis, we performed rescue experiments by overexpress-
ing scl and lmo2 into the RA-treated embryos. The results showed
that the overexpression not only rescued the suppressed expres-
sions of both etsrp and gata2 in the rostral part but also induced
their ectopical expressions in the caudal part of ALPM (Figure 5B,
5D; 5F and 5H). Consequently, the inhibited expressions of both
lcp1 and mpx were partially rescued at 24 hpf when the RA-treated
embryos were microinjected with scl and lmo2 mRNA (Figure 5J,
5L, 5N and 5P). Interestingly, the control embryos overexpressed
with scl and lmo2 exhibited similar expression levels of lcp1 and mpx
to wild type embryos at 24 hpf (Figure 5I, 5K, 5M and 5O) though
they had significantly up-regulated expressions of etsrp and gata2 in
ALPM at 14 hpf (Figure 5A, 5C, 5E and 5G). Consistently, our
Figure 4. ALPM is lost in the embryos treated with 50 nM RA from 1–2-cell stage to 11 hpf but not eliminated in the ones treated
with 250 nM RA during 10–11 hpf. All embryos including flat-mounted embryos (A–C, H–O) and whole-mounted embryos (D–G) are positioned
anterior left and dorsal front (A–C, H–O) or lateral front (D–G). Embryos treated with vehicle DMSO (A), 50 nM RA from 1–2-cell stage to 11 hpf (B), and
250 nM RA during 10–11 hpf (C) were examined for hoxb5b expression at 11 hpf (A–C). Embryos treated with 50 nM RA treatment from 1–2-cell stage
to 11 hpf displayed ectopically expression of hoxb5b in ALPM (B) but the ones treated with 250 nM RA during 10–11 hpf did not exhibit this ectopical
expression (C). Compared with control embryos (D, F), overexpressions of hoxb5b by microinjecting embryos at 1–2-cell stage with hoxb5b mRNA
significantly suppressed expressions of lcp1 (E) and mpx (G) at 24 hpf. Embryos treated with vehicle DMSO (H, J), 50 nM RA from 1–2-cell stage to 14
hpf (I) or 250 nM RA during 10–11 hpf (K) were examined for expressions of ALPM marker gata4 at 14 hpf. The location of ALPM at 11 hpf (A–C) or at
14 hpf (H, J, K) is indicated by bracket. Embryos treated with vehicle DMSO (L), 250 nM RA during 10–11 hpf (M, O), or microinjected with scl/lmo2
mRNA (N, O) were examined for expressions of cardiac marker hand2 at 14 hpf. Expression of myoD in somites (H–O) was used for staging and ntl
expression was used for labeling embryonic axial mesoderm (J–O). The length between the anterior end of gata4 expression domain (J, K) or hand 2
expression domain (L–N) and the anterior end of ntl expression domain and the length between the posterior end of gata4 expression domain (J, K)
or hand 2 expression domain (L–N) and the anterior end of ntl expression domain are marked by two different brackets. Red line denotes the anterior
level of ntl expression domain (J–O). Arrow indicates the most anterior end of notochord marked by expression of ntl (J–O). sc: spinal cord; PLPM:
posterior lateral plate mesoderm. The number shown in the lower left-hand corner of each panel is the number of embryos exhibiting the typical
phenotype shown in the panel to the number of embryos totally observed.
doi:10.1371/journal.pone.0030865.g004
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mpx for the myeloid cells originated from RBI by removing the
trunk and tail of the embryos with different treatments showed
that overexpressions of scl and lmo2 significantly up-regulated
(P,0.01) the expressions of lcp1 and mpx in the RA-treated
embryos but did not change them (P.0.05) in control embryos
(Figure S2).
Taken together, the results suggest that RA signaling acts
upstream of scl/lmo2 to control zebrafish primitive myelopoiesis.
RA signaling acts upstream of, or parallel to, cloche to
inhibit zebrafish primitive myelopoiesis
cloche acts upstream of scl to regulate development of
hematopoietic and vascular tissues [24,25,26]. To explore epistatic
relationship of RA signaling with cloche, we should examine
expression changes of cloche in RA signaling-altered embryos.
Unfortunately, we could not monitor cloche expressions because of
low expression of the only candidate lycat [27]. We therefore
examined expressions of lcp1 and mpx in cloche embryos treated
with 10 mM DEAB (4-diethylamino-benzaldehyde), a retinal
dehydrogenase inhibitor, to see whether decreasing RA signaling
could rescue the defect of primitive myelopoiesis in cloche. cloche
embryos hardly expressed lcp1 and mpx (Figure 6B and 6H) while
their heterozygous siblings showed normal expression levels
(Figure 6A and 6G). When treated with 10 mM DEAB, the sibling
embryos of cloche exhibited significantly increased expressions of
lcp1 and mpx (Figure 6D and 6J), which is consistent with RA’s
suppressing role in zebrafish primitive myelopoiesis. However,
DEAB treatment could not rescue expressions of the two genes in
cloche embryos (Figure 6C and 6I). It is known that knocking down
lycat phenocopies cloche [27]. We therefore examined the primitive
myelopoiesis in lycat morphants that were treated with 10 mM
DEAB. Similar to that in cloche embryos, DEAB treatment did not
rescue expressions of lcp1 and mpx that were depleted in lycat
knockdown embryos (Figure 6E, 6F, 6K and 6L). Taken together,
these results support that RA signaling lies upstream of, or parallel
to, cloche to suppress the primitive myelopoiesis.
RA signaling acts downstream of gata4/5/6 to control
zebrafish primitive myelopoiesis
gata4, gata5 and gata6 are known to lie above cloche and scl
controlling primitive myelopoiesis [21]. Because gata4 expression
was slightly reduced in the 250 nM RA-treated embryos
(Figure 4K), we therefore examined whether the expressions of
gata5 and gata6 were changed in the embryos with the same
treatment. When compared to control embryos (Figure S3A and
S3C), the RA-treated embryos exhibited similar expression of gata5
but somehow increased expression of gata6 in the region between
the anterior ends of their expression domains and the anterior end
of ntl expression domain, respectively (Figure S3B and S3D);
however, they displayed significantly increased gata5 expression but
greatly reduced gata6 expression in the region between the posterior
end of their expression domains and the anterior end of ntl
expression domain, respectively (Figure S3). Because the rostral part
ofALPMisresponsiblefortheformationofanteriorhemangioblasts
[21], these results imply that RA signaling should not act upstream
of gata4/5/6 to control the primitive myelopoiesis.
To explore whether RA signaling works downstream of gata4/
5/6, we first examined whether reducing RA signaling could
reverse the phenotype of the abolished primitive myelopoiesis in
gata4/5/6 depleted embryos. Because gata4 is not expressed in
gata5/6 double morphants, the double knockdown is actually a
triple knockdown [21]. We therefore depleted expressions of
gata4/5/6 by microinjecting gata5-MO and gata6-MO into
zebrafish embryos. When the gata4/5/6 depleted embryos were
treated with 10 mM DEAB from 1–2-cell stage to 24 hpf, the
Figure 5. Overexpressions of scl and lmo2 into RA-treated zebrafish embryos partially rescue the defective primitive myelopoiesis.
Both flat-mounted embryos (A–H) and whole-mounted embryos (I–P) are positioned anterior left and dorsal front (A–H) or lateral front (I–P). Embryos
were treated with vehicle DMSO (A, E, I, M), 250 nM RA during 10 to 11 hpf (B, F, J, N), or microinjected with scl and lmo2 mRNA at 1–2-cell stage (C, G,
K, O), or microinjected with scl and lmo2 mRNA at 1–2-cell stage and then treated with 250 nM RA during 10 to 11 hpf (D, H, L, P), respectively. They
were then examined for expressions of hemangioblast markers etsrp (A–D) and gata2 (E–H) at 14 hpf, and myeloid markers lcp1 (I–L) and mpx (M–P)
at 24 hpf by whole mount in situ hybridization. Expression of myoD in somites was used for staging (A–H). Bracket indicates the location of RBI (A, B,
E, F), and ALPM (C, D, G, H). The number shown in the lower left-hand corner of each panel is the number of embryos exhibiting the typical
phenotype shown in the panel to the number of embryos totally observed.
doi:10.1371/journal.pone.0030865.g005
RA Restricts Zebrafish Primitive Myelopoiesis
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rescued in 82% (36/44) and 79% (27/34) of the embryos
respectively (Figure 7C and 7H). Additionally, treating the
gata4/5/6 depleted embryos with 10 mM DEAB starting from
different developmental stages including 3 hpf, 5 hfp, 7 hpf and 9
hpf but not 11 hpf well rescued the ablated expressions of lcp1 and
mpx (Figure S4). The result suggests that RA signaling works
downstream gata4/5/6 to inhibit the primitive myelopoiesis. To
further support this conclusion, we performed overexpression
experiment. We found that overexpressions of gata4 and gata6 in
control embryos significantly increased expressions of lcp1 and mpx
(Figure 7D and 7I). However, the increased expressions of lcp1 and
mpx were greatly reduced when the embryos were treated with
250 nM RA during 10–11 hpf (Figure 7E and 7J). Quantitative
Figure 6. DEAB cannot rescue the defective primitive myelopoiesis in cloche or lycat knockdown embryos. All embryos are positioned
anterior left and lateral front. Wild type siblings (A, G), cloche (B, H) and the embryos microinjected with lycat-MO at 1–2-cell stage (E, K) were treated
with vehicle DMSO whereas cloche (C, I), cloche siblings (D, J) and lycat-MO knockdown (F, L) embryos were treated with 10 mM DEAB from 1–2-cell
stage until 26 hpf. They were then examined for expressions of myeloid markers lcp1 (A–F) and mpx (G–L) at 26 hpf by whole mount in situ
hybridization. The number shown in the lower left-hand corner of each panel is the number of embryos exhibiting the typical phenotype shown in
the panel to the number of embryos totally observed.
doi:10.1371/journal.pone.0030865.g006
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PCR confirmed that RA treatment blocked the increased
expressions of lcp1 and mpx in the embryos overexpressed with
gata4/6 mRNAs (Figure S5). Taken together, the results
demonstrate that RA signaling works downstream of gata4/5/6
to control zebrafish primitive myelopoiesis.
aldh1a2 is the major gene that is in charge of RA synthesis
during zebrafish early development [28,29]. To explore whether it
is responsible for mediating gata4/5/6 signaling to control the
primitive myelopoiesis, we examined expression changes of
aldh1a2 in gata4/5/6 depleted or gata4/6 overexpressed embryos.
The results showed that aldh1a2 expression was not changed in the
two types of embryos at 5 hpf (Figure 8A–C). It was slightly
expanded in the ventral mesoderm of gata4/5/6 depleted embryos
but significantly decreased in gata4/6 overexpressed embryos at 7
hpf and 9 hpf respectively (Figure 8D–I). At 11 hpf and 13 hpf,
aldh1a2 was significantly increased and ectopically expressed in
LPM of gata4/5/6 depleted embryos whereas its expression was
significantly reduced in both LPM and somites in gata4/6
overexpressed embryos (Figure 8J–O). Quantitative analyses by
real-time RT-PCR confirmed that its expression was significantly
increased in gata4/5/6 depleted embryos (Figure 8P) but reduced
in gata4/6 overexpressed embryos (Figure 8Q) at 7, 9, 11 and 13
but not 5 hpf, respectively. Moreover, the abolished expressions of
lcp1 and mpx in gata4/5/6 depleted embryos were partially rescued
to express respectively when the gata4/5/6 depleted embryos were
microinjected with aldh1a2-MO (Figure 8R–W). Quantitative
analysis by real-time PCR further confirmed this rescue result
(Figure 8X). Taken together, our observations suggest aldh1a2 is
one of the candidate genes that work downstream of gata4/5/6 to
control the primitive myelopoiesis.
Discussion
Unlike mammals and birds whose primitive hematopoiesis
generates a small number of primitive macrophages and no
granulocytes, zebrafish primitive hematopoiesis produces func-
tional granulocytes and macrophages [2,6,8]. Although it is not
known how zebrafish primitive myeloid pathway relates to
mammalian definitive myelopoiesis, the primitive myelopoiesis
has been widely used to assess myelopoiesis [11,30]. RA has been
implicated in regulating definitive myelopoiesis [14,15], but little is
known about its role in primitive myelopoiesis. Here we report
that RA suppresses zebrafish primitive myelopoiesis in a dose
Figure 7. RA inhibits primitive myelopoiesis by acting downstream of gata4/5/6. All embryos are positioned anterior left and lateral front.
Embryos were microinjected with gata5-MO and gata6-MO together (B, C, G, H) at 1–2-cell stage and then treated with 10 mM DEAB (C, H) or vehicle
DMSO (B, G) immediately, or microinjected with gata4 mRNA and gata6 mRNA together (D, E, I, J) and then treated with 250 nM RA (E, J) or vehicle
DMSO (D, I) from 10 to 11 hpf, respectively. They were then examined for expressions of myeloid markers lcp1 (A–E) and mpx (F–J) at 24 hpf by whole
mount in situ hybridization. The number shown in the lower left-hand corner of each panel is the number of embryos exhibiting the typical
phenotype shown in the panel to the number of embryos totally observed.
doi:10.1371/journal.pone.0030865.g007
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hemangioblasts are initiated to form (Figure 2) whereas reducing
endogenous RA signaling increases the myelopoiesis (Figure 6D
and 6J). Our results are consistent with the previous observations
from VAD mice, CRBPI-knock-out mice and RAR antogonist
BMS493 treated mice showing that shortage of RA signaling
causes myeloid cell expansion [17,18], and recently researches
revealing that DEAB increases myeloid cells in zebrafish [31].
However, studies on APL treatment reveal that RA relieves the
disease by promoting terminal granulocytic differentiation of
malignant promyelocytes [12,15]. Consistently, in vitro researches
show that RA enhances differentiation of granulocyte progenitors
derived from the hematopoietic precursor cells in bone marrow or
fetal liver [14] and generation of differentiated hematopoietic cells
from human embryonic stem cell-derived hemato-vascular
precursors [32]. Taken together, these observations suggest that
RA restricts normal myelopoiesis but promotes myeloid differen-
tiation of hematopoietic precursors.
Zebrafish primitive myelopoiesis initiates in RBI by expressing
transcription factors such as scl, lmo2, gata2, and etsrp [5,24,33] and
then acquires myeloid cell fate through expressing pu.1 [6,7].
Recent reports have shown that treating embryos with excessive
RA before late gastrulation reduces or eliminates the expression of
ALPM markers including gata4 [34], scl and pu.1 [35]. Consis-
tently, we report in this study that treating embryos with
exogenous RA in a concentration as low as 50 nM before 11
hpf abolishes expressions of the ALPM markers including gata4
(Figure 4I), pu.1 (Figure 3C), scl (Figure 3F), lmo2 (Figure 3I), etsrp
(Figure 3L) and gata2 (Figure 3O), leading to developmental loss of
primitive myelopoiesis.
It is known that excessive RA posteriorizes vertebrate embryos
during gastrulation [12,19], raising the possibility that the
Figure 8. aldh1a2 is one of downstream target genes of gata4/5/6 to affect zebrafish primitive myelopoiesis. Embryos are positioned
animal pole top and ventral front (A–I), anterior top and dorsal front (J–O), and anterior left and lateral front (R–W). Embryos were microinjected with
control MO (A, D, G, J, M, R, U), gata5-MO plus gata6-MO (B, E, H, K, N), gata4 mRNA plus gata6 mRNA (C, F, I, L, O), gata5-MO and gata6-MO plus
control MO (S, V), gata5-MO and gata6-MO plus aldh1a2 MO (T, W) at 1–2-cell stage, respectively. They were then examined for expressions of
aldh1a2 at 5 hpf (A–C), 7 hpf (D–F), 9 hpf (G–I), 11 hpf (J–L) and 13 hpf (M–O), lcp1 (R–T) and mpx at 24 hpf (U–W) by whole mount in situ
hybridization, respectively. qRT-PCR was performed to confirm the relative expression level changes of aldh1a2 in gata4/5/6 depleted embryos (P) or
in gata4/6 overexpressed embryos (Q) at 5, 7, 9, 11, 13 hpf, and those of lcp1 and mpx at 24 hpf (X). The number shown in the lower left-hand corner
of each panel (R–W) is the number of embryos exhibiting the typical phenotype shown in the panel to the number of embryos totally observed. *:
P,0.05; **: P,0.01.
doi:10.1371/journal.pone.0030865.g008
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treatment at early development might be secondary to global loss
of cells for ALPM tissue fate. Consistent with the idea, our results
showed that treating embryos with 50 nM RA from 1–2-cell stage
to 11 hpf caused hoxb5b, an RA direct target gene that acts
downstream of RA signaling in the forelimb field to restrict heart
field potential in zebrafish embryos [20], expanding its expression
to whole ALPM of 11 hpf embryos (Figure 4B). Additionally, gata4,
an ALPM marker [21], was almost abolished its expression in
whole ALPM of the 50 nM RA-treated embryos (Figure 4I), which
supports the conclusion that excessive RA treatment at early stage
may cause global loss of cells for ALPM tissue fate.
However, the induced expression of hoxb5b was not expanded to
ALPM but confined to PLPM in the embryos treated with 250 nM
RA during 10–11 hpf (Figure 4C). Consistently, the RA-treated
embryos only slightly reduced expression of gata4, an ALPM
marker [21], in the rostral portion of ALPM (Figure 4K).
Moreover, overexpression of scl and lmo2 partially rescued the
primitive myelopoiesis abolished in the RA-treated embryos
(Figure 5J, 5L, 5N and 5P) but it cannot increase the development
of myeloid cells ectopically in wild type embryos [36] (also see
Figure 5I, 5K, 5M and 5O). Taken together, these observations
suggest the suppressed formation of anterior hemangioblasts in the
250 nM RA-treated embryos cannot be ascribed to the abolish-
ment of anterior mesoderm in ALPM. Therefore, the embryos
treated with 250 nM RA during 10–11 hpf provide us a useful
model for analyzing direct roles of RA signaling in zebrafish
primitive myelopoiesis.
The entire ALPM in early zebrafish embryo possesses cardiac
developmental potential and the specification of anterior heman-
gioblasts represses formation of cardiac progenitors in the rostral
portion of ALPM [22]. Embryos with defects in anterior
hemangioblast specification exhibit ectopic cardiac progenitors
in the rostral portion whereas overexpression of hemangioblast
master regulators suppresses the cardiac development in the
caudal portion of ALPM [22]. In this study, we report that hand2,
the marker of cardiac precursors normally expressed in the caudal
end of ALPM (Figure 4L) [22,23,37], was ectopically expressed in
the whole rostral portion of ALPM in the RA-treated embryos that
lacked anterior hemangioblasts (Figure 4M) whereas overexpres-
sions of scl and lmo2 greatly reduced or even eliminated the ectopic
expression of the cardiac marker that was expressed in the RA-
treated embryos (Figure 4M and 4O). The results demonstrate
that RA signaling shifts the developmental potential of the anterior
mesoderm into the posterior fate of ALPM, enabling the
precursors in this region will no longer develop into myeloid cells.
Zebrafish primitive myelopoiesis is genetically controlled by
many genes. scl plays a pivotal role in primitive hematopoiesis [3].
It works together with lmo2 to define hemangioblast during
zebrafish early development [38]. Epistatic analyses have shown
that cloche acts upstream of scl, lmo2, and etsrp [5,26,33,39], and
gata4/5/6 acts upstream of, or parallel to cloche and upstream of scl
[21] to control zebrafish primitive myelopoiesis. Recently, RA was
demonstrated to inhibit the commitment of mesodermal cells to
hematopoietic fates by functioning downstream of cdx4 and
upstream of scl [35]. In this study, we report that RA suppresses
the primitive myelopoiesis by inhibiting expressions of scl and lmo2
(Figure 3F and 3I) and the inhibited primitive myelopoiesis is
partially rescued when scl and lmo2 are overexpressed (Figure 5L
and 5P). The results demonstrate that RA signaling works
upstream of scl to regulate the primitive myelopoiesis. However,
the abolished primitive myelopoiesis in neither cloche embryos nor
lycat morphants can be rescued by DEAB (Figure 6), indicating
that RA works upstream of, or parallels to, cloche.
RA has been shown to enhance GATA4 expression in F9 cells
[40] and P19 cells [41], and improve both GATA4 and GATA6 but
not GATA5 expression in mouse embryonic stem cells (ES) [42,43].
In VAD quail embryos, GATA4 fails to be expressed whereas
adding RA restores its expression pattern [44]. In Xenopus
embryos, excessive RA causes expanded expressions of GATA4/
5/6 [45]. Consistent with its enhancing expressions of the GATA
factors, RA commits mouse ES cells to differentiate into endoderm
by enhancing expressions of GATA6 and GATA4 [42,46], and
directs urothelial specification of the ES cells by activating
GATA4/6 signaling [43]. However, gata4 expression was signifi-
cantly reduced or completely abolished respectively in zebrafish
embryos at 8-somite stage that were treated with 100 nM RA or
300 nM RA at 40% epiboly for 1 h [34]. We show here that the
embryos treated with 50 nM RA from 1–2-cell stage to 14 hpf
displayed almost no gata4 expression (Figure 4I) whereas the
embryos treated with 250 nM RA during 10–11 hpf exhibited
slightly reduced gata4 expression (Figure 4K), unchanged gata5
expression (Figure S3B) and somehow increased gata6 expression
(Figure S3D) in the rostral portion of their ALPM. Moreover, we
revealed that DEAB could well rescue the abolished primitive
myelopoiesis in gata4/5/6 depleted embryos whereas RA blocked
the increased primitive myelopoiesis in gata4/6 overexpressed
embryos (Figure 7). Taken together, our results demonstrate that
RA signaling acts downstream of gata4/5/6 to control zebrafish
primitive myelopoiesis. Consistently, we found overexpressions of
gata4/6 significantly inhibited expression of aldh1a2,t h em a j o r
gene that is responsible for RA synthesis during early develop-
ment [28,29], whereas depleting gata4/5/6 increased aldh1a2
expression in zebrafish embryos (Figure 8). However, knocking
down aldh1a2 only partially rescued the abolished primitive
myelopoiesis in gata4/5/6 depleted embryos (Figure 8), which is
consistent with recent survey revealing that knocking down both
aldh1a2 and aldh1a3 cannot recapitulate the hematopoietic
expansion like happening in DEAB-treated embryos [31]. The
results suggest that other DEAB-sensitive aldehyde dehydroge-
nases should work downstream of gata4/5/6 to restrict zebrafish
primitive myelopoiesis.
In summary, our results demonstrate that RA signaling acts
downstream of gata4/5/6, upstream of, or parallel to, cloche, and
upstream of scl to suppress zebrafish primitive myelopoiesis by
restricting the formation of anterior hemangioblasts (Figure S6) in
a dose dependent way.
Materials and Methods
Ethics statement
Zebrafish used in this study are housed in the zebrafish facility
of Model Animal Research Center (MARC), Nanjing University,
in accordance with IACUC-approved protocol (MARC-AP#:
QZ01).
Pharmaceutical treatment of zebrafish embryos with RA
and DEAB
All-trans RA, 4-diethylamino benzaldehyde (DEAB) and
d i m e t h y ls u l f o x i d e( D M S O )w e r epurchased from Sigma-Aldrich
(MO, USA). A stock solution of 0.2 mM RA and 1 mM DEAB
were prepared with DMSO and stored at –80uC. Embryos
c o l l e c t e df r o mw i l dt y p ez e b r a f i s ho rcloche mutant [39] were
grown at 28.5uC and staged as previously reported [47].
Different concentrations of RA or DEAB were administrated
to increase or reduce RA signaling in zebrafish embryos, re-
spectively. The final concentration of DMSO in each treatment
and control is 0.1%.
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Morpholinos (MOs) were purchased from Gene Tools (http://
www.gene-tools.com). The sequences of antisense MOs were listed
in Table S1. Control MO was the standard MO provided by Gene
Tools. MOs were dissolved in nanopure water and injected into
the embryos at 1–2-cell stages. The injected amount per embryo
was about 1 nl solution containing 1 ng cyp26a1-MO plus 2 ng
cyp26b1-MO plus 2 ng cyp26c1-MO, 8 ng aldh1a2-MO plus
6.25 ng gata5-MO plus 1.25 ng gata6-MO, 6.25 ng gata5-MO plus
1.25 ng gata6-MO, or 4 ng lycat-MO, respectively.
In vitro synthesis of mRNA and microinjection of mRNAs
into zebrafish embryos
To synthesize mRNA in vitro, we first cloned the full-length
coding sequences of gata4 [48], gata6 [49], hoxb5b [34], lmo2 [24]
and scl [33] by RT-PCR using primers listed in Table S2. The
cDNAs were cloned into pGEM-T vector (Promega, USA) using
HF PCR Kit (Takara, Japan) and then confirmed their identities
by direct sequencing from both ends. The fragments were then
cloned into the modified expression vector of pxT7 with 59- and
39-UTR of zebrafish b-globin [50] by digesting with EcoRI. The
capped and tailed mRNA of these genes was generated from
linearized pxT7 plasmid containing zebrafish gata4, gata6, hoxb5b,
lmo2 or scl coding sequence using the mMESSAGE mMACHINE
T7 Ultra Kit (Ambion, USA). The synthesized mRNAs were
further purified with RNeasy Kit (Qiagen, German) to remove the
free nucleotides. Embryos were microinjected at 1–2-cell stage.
The injected amount per embryo was about 1 nl solution
containing 100 pg of scl and lmo2, 150 pg of hoxb5b,o r2 5p go f
gata4 and gata6, respectively.
Whole mount in situ hybridizations
Whole mount in situ hybridizations were performed as described
previously [51]. The templates for anti-sense RNA probes
including etsrp [52], gata2 [24], gata5 [53], and hand2 [23] were
cloned using the primers listed in Table S3. The templates for anti-
sense RNA probes including scl, gata4, gata6 and hoxb5b are the
same as those used for mRNA synthesis. The plasmids containing
the probe templates of mpx, lcp1, pu.1 [6], ntl and lmo2 [24] were
kindly given by Dr. Yeh [54] and Dr. Zhang [55]. Other probes
including myoD, cyp26a1 and aldh1a2 were used as previously
reported [19]. Photomicrographs were taken using Olympus DP71
digital camera (Olympus, Japan). Digital images were further
processed for brightness and contrast with Adobe Photoshop
software.
Real-time RT-PCR assay
Quantitative reverse transcription-polymerase chain reaction
(qRT-PCR) was performed to examine the relative expression
levels of aldh1a2, lcp1, mpx and b-actin (for control) using the ABI
Prism 7300 Sequence Detector (PE Biosystems, USA). Total
RNAs were extracted from 30 embryos using Trizol reagent
(Invitrogen, USA) for each assay. RNA was reverse-transcribed
and PCR was performed using the SYBR Green method following
the manufacturer’s protocol. Primers used for qRT-PCR were
listed in Table S4. Relative quantification of each gene expression
was performed by the comparative CT methods. Transcript level
of examined genes was normalized to b-actin mRNA level
according to standard procedures. Data were shown as means 6
SD (standard deviation). Comparisons between numerical data
were evaluated by unpaired Student t test. P value less than 0.05
was considered statistically significant. Every experiment was
independently performed at least twice.
Supporting Information
Figure S1 qRT-PCR analysis shows the relative expres-
sion levels of lcp1 and mpx are significantly reduced in
cyp26s morphants. Embryos were microinjected with control
MO (Control MO) or cyp26a1-MO plus cyp26b1-MO plus cyp26c1-
MO (cyp26s MO) at 1–2-cell stage and then examined for
expressions of myeloid markers lcp1 and mpx at 26 hpf by qRT-
PCR. *: P,0.05.
(TIF)
Figure S2 qRT-PCR analysis shows overexpression of
scl and lmo2 into zebrafish embryos partially rescues
the defective primitive myelopoiesis in the embryos
treated with 250 nM RA during 10–11 hpf. Embryos were
treated with vehicle DMSO (WT), microinjected with scl and lmo2
mRNA at 1–2 cell stage (scl/lmo2 mRNA), treated with 250 nM
RA during 10 to 11 hpf (250 nM RA 10–11 hpf), or microinjected
with scl and lmo2 mRNA at 1–2-cell stage and then treated with
250 nM RA during 10 to 11hpf (RA+scl/lmo2 mRNA), respec-
tively. To exclude the myeloid cells derived from ICM, embryos
that were removed tails and trunks at 24 hpf were used to detect
relative expression levels of myeloid markers lcp1 and mpx by qRT-
PCR. Overexpression of scl and lmo2 did not change expression
levels of lcp1 and mpx in wild type embryos but significantly
rescued the inhibited expressions of lcp1 and mpx in the embryos
treated with 250 nM during 10–11 hpf. **: P,0.01.
(TIF)
Figure S3 Effect of excessive RA treatment during 10–11
hpf on expressions of gata5 and gata6 in the RA-treated
embryos at 14 hpf. All flat-mounted embryos are positioned
anterior left and dorsal front. Embryos treated with vehicle
DMSO (A, C) and 250 nM RA from 10–11 hpf were examined
for expressions of gata5 (A, B) and gata6 (C, D) at 14 hpf,
respectively. Expression of myoD in somites was used for staging
and ntl expression was used for labeling embryonic axial
mesoderm. The number shown in the lower left-hand corner of
each panel is the number of embryos exhibiting the typical
phenotype shown in the panel to the number of embryos totally
observed. The embryos treated with 250 nM RA from 10–11 hpf
exhibited similar expression of gata5 but somehow increased
expression of gata6 in the region between the anterior ends of their
expression domains and the anterior end of ntl expression domain;
however, they displayed significantly increased gata5 expression
but greatly reduced gata6 expression in the region between the
posterior ends of their expression domains and the anterior end of
ntl expression domain, respectively.
(TIF)
Figure S4 The ablated primitive myelopoiesis in gata4/
5/6-depleted embryos can be rescued by treating with
10 mM DEAB starting before 11 hpf. All embryos were
positioned anterior left and lateral front. Embryos were microin-
jected with gata4-MO and gata6-MO at 1–2-cell stage (B–H, J–P)
and then treated with vehicle DMSO (B, J) or 10 mM DEAB
continuously starting from 1–2-cell stage (C, K), 3 hpf (D, L), 5 hpf
(E, M), 7 hpf (F, N), 9 hpf (G, O), and 11 hpf (H, P), respectively.
The embryos were then grown together with wild type control
embryos (A, I) to 24 hpf for examining expressions of myeloid
markers lcp1 (A–H) and mpx (I, P) respectively. The number
shown in the lower left-hand corner of each panel is the number
of embryos exhibiting the typical phenotype shown in the panel
to the number of embryos totally observed. Treatment with
DEAB before 11 hpf can well rescue the abolished primitive
myelopoiesis in gata4/5/6-depleted embryos (C–G; K–O) whereas
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myelopoiesis (H, P).
(TIF)
Figure S5 qRT-PCR analysis shows that the increased
primitive myelopoiesis due to overexpressing gata4/6 is
blocked by treating the embryos with 250 nM RA during
10–11 hpf. Embryos were microinjected with gata4 mRNA plus
gata6 mRNA at 1–2-cell stage. They were treated with 250 nM
RA (gata4/6 mRNA+RA) or vehicle DMSO (gata4/6 mRNA)
during 10–11 hpf and then grown with wild type embryos (WT) to
24 hpf for examining expression level changes of myeloid markers
lcp1 and mpx by qRT-PCR. Overexpressing gata4/6 into wild type
embryos significantly increased expressions of lcp1 and mpx but the
increased expressions were blocked by treating the embryos with
250 nM RA during 10–11 hpf. *: P,0.05; **: P,0.01.
(TIF)
Figure S6 Proposed model showing the epistatic rela-
tionship of RA signaling with the genes controlling
zebrafish primitive myelopoiesis. RA signaling works
downstream of gata4/5/6, upstream of, or parallel to cloche, and
upstream of scl to control the formation of anterior hemangioblasts
marked by expressions of scl, lmo2, gata2 and etsrp that give rise to
the primitive myeloid precursors marked by expression of pu.1.
(TIF)
Table S1 Sequences of morpholinos used.
(DOC)
Table S2 Sequences of primers used in cloning full-
length cDNAs for in vitro mRNA synthesis.
(DOC)
Table S3 Sequences of primers used in cloning cDNAs
for RNA probes.
(DOC)
Table S4 Sequences of primers used in qRT-PCR.
(DOC)
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